ACORN CAPITAL ADVISORS, LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$143.7B
Holdings
22
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 1,131,501 | $27.7B | 19.29% | |
| 2 | URGNUROGEN PHARMA LTD | 1,516,303 | $16.8B | 11.67% | |
| 3 | YMABUSDY-MABS THERAPEUTICS INC | 3,235,387 | $14.3B | 9.97% | |
| 4 | TRVITREVI THERAPEUTICS INC | 2,144,844 | $13.5B | 9.39% | |
| 5 | CADLCANDEL THERAPEUTICS INC | 2,152,252 | $12.2B | 8.46% | |
| 6 | PBYIPUMA BIOTECHNOLOGY INC | 3,940,052 | $11.7B | 8.12% | |
| 7 | BCAXBICARA THERAPEUTICS | 643,382 | $8.4B | 5.83% | |
| 8 | TARAPROTARA THERAPEUTICS INC | 1,279,800 | $5.5B | 3.79% | |
| 9 | TERNTERNS PHARMACEUTICALS INC | 1,971,264 | $5.4B | 3.79% | |
| 10 | HELPCYBIN INC | 734,394 | $4.7B | 3.25% | |
| 11 | CRDFCARDIF ONCOLOGY INC | 1,442,308 | $4.5B | 3.15% | |
| 12 | 0OPOPTINOSE INC | 422,814 | $3.9B | 2.70% | |
| 13 | VSTMVERASTEM INC | 452,110 | $2.7B | 1.90% | |
| 14 | WHWKWHITEHAWK THERAPEUTICS INC | 1,139,363 | $2.0B | 1.41% | |
| 15 | ASNSUSDX4 PHARMACEUTICALS INC | 7,310,650 | $1.8B | 1.22% | |
| 16 | —MURAL ONCOLOGY PLC | 1,269,715 | $1.6B | 1.11% | |
| 17 | AURAAURA BIOSCIENCES INC | 590,508 | $1.5B | 1.01% | |
| 18 | BCABBIOATLA INC | 4,032,046 | $1.4B | 0.98% | |
| 19 | QTTBQ32 BIO INC. | 803,425 | $1.3B | 0.92% | |
| 20 | VYNEVYNE THERAPEUTICS INC | 785,938 | $1.2B | 0.86% | |
| 21 | OKURONKURE THERAPEUTICS INC | 199,189 | $856.5M | 0.60% | |
| 22 | ACRVACRIVON THERAPEUTICS INC | 405,237 | $822.6M | 0.57% |